About us

Synthon Chiragenics Corporation is a world-leader in carbohydrate-based chiral technology for pharmaceuticals. Unlike proteins and amino acids that have been the target of biomedical research for decades, carbohydrate chemistry has eluded researchers because of the complexity of the molecules and the difficulty of working with them. Synthon is the first and only company to unlock the rich source of chirality contained in naturally occurring carbohydrates. The company uses its proprietary technology to economically construct the most challenging chiral molecules, which serve as cores for drugs being developed in the fastest-growing therapeutic areas: anti-virals, antibiotics and anti-cancer. These "drugs of the future" are the most difficult and expensive to make because they possess multiple chiral centers. The company's strategy is to start with naturally occurring, readily available carbohydrates that have the chirality already built-in. Carbohydrates are unique because they have multiple contiguous chiral centers, which can be manipulated to form desired drug intermediates more cost-effectively than other methods. Synthon offers its technology to the pharmaceutical marketplace through a number of products and services, including: Chiral building blocks for drug discovery, d…...